China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'CAV-1 Regulates Neutrophil Lipoprotein Endocytosis to Drive NETosis and Promote Coronary Atherosclerosis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134668
Registration Time: 2026/10/19
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347762
Published by HT Digital Content Services with permission from Health Daily Digest....